GeneDx Holdings (WGSWW) EBT Margin (2020 - 2026)

GeneDx Holdings (WGSWW) has 7 years of EBT Margin data on file, last reported at 61.04% in Q1 2026.

• EBT Margin for Q1 2026 came in at 61.04%, down 5406.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 17.5% (down 587.0% YoY), and the FY2025 annual result was 4.94%, up 1229.0% from the prior year.
• EBT Margin declined to 61.04% in Q1 2026 per WGSWW's latest filing, from 15.07% in the prior quarter.
• Over five years, EBT Margin peaked at 10.29% in Q2 2025 and troughed at 503.13% in Q4 2022.
• A 5-year average of 96.09% and a median of 45.6% in 2023 frame the typical range for EBT Margin.
• The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 43361 bps in 2022, then jumped 45753 bps in 2023.
• A 5-year view of EBT Margin shows it stood at 503.13% in 2022, then surged by 91 bps to 45.6% in 2023, then soared by 112 bps to 5.66% in 2024, then slumped by 366 bps to 15.07% in 2025, then tumbled by 305 bps to 61.04% in 2026.
• Business Quant data shows WGSWW's EBT Margin at 61.04% in Q1 2026, 15.07% in Q4 2025, and 6.33% in Q3 2025.